Kelly Services® Adds D. Hugo Malan to Senior Leadership Team; Named President of New STEM Business Unit

Written by Customer Service on March 5, 2020. Posted in Public Companies.

TROY, Mich., March 05, 2020 (GLOBE NEWSWIRE) — Kelly Services Inc. (Nasdaq: KELYA, KELYB), a global leader in providing workforce solutions, today announced the hiring of D. Hugo Malan as Senior Vice President and President of the STEM specialty business being formed as part of Kelly’s new structure announced in February by President and Chief Executive Officer Peter Quigley.With approximately 20 years of wide-ranging business leadership experience, Malan brings a fresh perspective to Kelly as the company accelerates its transformation into a leading specialty talent solutions provider. Malan will have overall responsibility for Kelly’s Science, Engineering and IT business portfolios and related product offerings while driving strategy and seamless execution of all aspects of the STEM business.“We are thrilled to welcome to our...

Arbutus Reports Fourth Quarter and Year End 2019 Financial Results, Confirms 2020 Corporate Objectives and Provides Pipeline Update

Written by Customer Service on March 5, 2020. Posted in Public Companies.

Conference Call and Webcast Scheduled Today at 8:45 AM ETWARMINSTER, Pa., March 05, 2020 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a Hepatitis B Virus (HBV) therapeutic solutions company, today reports its fourth quarter and year end 2019 financial results, confirms 2020 corporate objectives and provides pipeline update.“Arbutus is focused on developing a portfolio of medicines with different mechanisms of action that we believe could provide a functional cure for people with chronic hepatitis B,” said William Collier, Arbutus’ President and Chief Executive Officer. “Our key objectives for 2020 are to complete and report results from the Phase 1a/b clinical trial of AB-729, our proprietary subcutaneous RNAi agent, and rapidly advance our next-generation oral capsid inhibitor, AB-836, through IND-enabling studies...

Harpoon Therapeutics to Report Fourth Quarter 2019 Financial Results and Provide Corporate Update

Written by Customer Service on March 5, 2020. Posted in Public Companies.

SOUTH SAN FRANCISCO, Calif., March 05, 2020 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, announced today that it will report fourth quarter and full year 2019 financial results and provide a corporate update on Thursday, March 12, 2020. Harpoon’s management will host a webcast and conference call at 4:30 p.m. ET / 1:30 p.m. PT.The live call may be accessed by dialing 866-951-6894 for domestic callers and 409-216-0624 for international callers and entering the conference code: 5468929. A live webcast and archive of the call will be available online from the investor relations section of the company website at www.harpoontx.com.About Harpoon TherapeuticsHarpoon Therapeutics is a clinical-stage immunotherapy company developing a novel...

Bellicum to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update

Written by Customer Service on March 5, 2020. Posted in Public Companies.

HOUSTON, March 05, 2020 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced it will report financial results for the fourth quarter and full year 2019 after the close of U.S. markets on Thursday, March 12, 2020. Management will host a webcast and conference call at 5 p.m. ET / 2 p.m. PT that day to discuss the financial results and provide a corporate update.The live call may be accessed by dialing 877-407-3103 (U.S. domestic) and 201-493-6791 (international) at least 10 minutes prior to the start of the call. The event will be webcast live and can also be accessed in the Events & Presentations section of bellicum.com. An archived version of the webcast will be available for replay in the Investors & Media section...

CloudMD Software & Services Inc. Announces Symbol Change on OTCQB

Written by Customer Service on March 5, 2020. Posted in Public Companies.

VANCOUVER, British Columbia, March 05, 2020 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (CSE: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a Company focused on revolutionizing the delivery of healthcare, is pleased to announce that, in connection with CloudMD’s recent name change, its ticker symbol on the OTCQB has changed from “PHGRF ” to “DOCRF” effective today.No action is needed from the Company’s current shareholders relative to the ticker symbol change.For more information on CloudMD visit www.cloudMD.ca.ON BEHALF OF THE BOARD OF DIRECTORS“Dr. Essam Hamza, MD”Chief Executive Officer About CloudMD Software & ServicesCloudMD is digitizing the delivery...

NexTech’s Revolutionary 3D AR Capture App “ARitize 360” Now Available for Early Access Signup

Written by Customer Service on March 5, 2020. Posted in Public Companies.

NEW YORK and TORONTO, March 05, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (the “Company” or “NexTech”) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29) NexTech, the industry leader in the rapidly growing augmented reality (AR) space, is excited to announce early access for one-hundred brands and businesses of its revolutionary 3D/AR capture app previously called CaptureAR, now rebranded as “ARitize360”.SEE VIDEO DEMO HEREEARLY ACCESS SIGNUP HEREThe company is offering free early access for one-hundred brands and businesses before launching a stand alone dual platform app called “ARitize360”. The app will employ the freemium business model, whereby a user gets a free 3D scan. However, a user will be billed for additional scan “packs” as well as be charged a monthly subscription fee for hosting the 3D asset. Together the two could add substantial...

Zai Lab to Announce Financial Results for the Full Year Ended December 31, 2019 and Corporate Updates on March 19, 2020

Written by Customer Service on March 5, 2020. Posted in Public Companies.

— Company to host Conference Call and Webcast on March 19, 2020 at 8:30 a.m. ETSHANGHAI, China and SAN FRANCISCO, March 05, 2020 (GLOBE NEWSWIRE) — Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced it will report financial results for the full year ended December 31, 2019 and corporate updates before the market opens on Thursday, March 19, 2020 and host a conference call at 8:30 a.m. ET. On the call, Zai Lab’s senior management team will also provide an update on the Company’s business and upcoming milestones.The live webcast and a replay may be accessed by visiting the Company’s website at http://ir.zailaboratory.com. Alternatively, please call (866) 5194004 (U.S.), +65 67135090 (International), 4006208038 (China), +852 30186771 (Hong Kong), or +44...

Day: March 5, 2020